These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11713709

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M, Kumari M, Shamsi T, Naz A, Farzana T.
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [Abstract] [Full Text] [Related]

  • 3. Development of inhibitors in haemophilia. Ongoing epidemiological study.
    Serban M, Mihailov D, Pop L, Ionita H, Ursu E, Talpos-Niculescu S, Ritli L, Baghiu D, Uscatescu V, Petrovanu C, Stancu P, Savescu D, Cucuianu A, Schramm W.
    Hamostaseologie; 2011 Nov; 31 Suppl 1():S20-3. PubMed ID: 22057218
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High titre inhibitor to factor VIII in a haemophilia carrier.
    Marino R, Malcangi G, Margaglione M, Ettorre CP.
    Haemophilia; 2014 May; 20(3):e237-40. PubMed ID: 24731130
    [No Abstract] [Full Text] [Related]

  • 8. [Inhibitor hemophilia A--diagnostic and therapeutic significance of controlled substitutions with factor VIII].
    Weippert M, Anders O, Schmidt M, Roewer J.
    Beitr Infusionsther; 1990 May; 26():174-8. PubMed ID: 1703823
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A cross-sectional survey of coagulation factor VIII inhibitor in children with hemophilia A].
    Wei Q, Li G, Tang L, Chen Z, Zhen Y, Wu X, Zhang N, Zhang J, Yu G, Wu R.
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):99-102. PubMed ID: 24739719
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required.
    Calvez T, Laurian Y.
    Br J Haematol; 2006 Mar; 132(6):798-800; author reply 800-1. PubMed ID: 16487187
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs.
    Ehrenforth S, Kreuz W, Scharrer I, Linde R, Funk M, Güngör T, Krackhardt B, Kornhuber B.
    Lancet; 1992 Mar 07; 339(8793):594-8. PubMed ID: 1347102
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product.
    Yee TT, Williams MD, Hill FG, Lee CA, Pasi KJ.
    Thromb Haemost; 1997 Sep 07; 78(3):1027-9. PubMed ID: 9308748
    [Abstract] [Full Text] [Related]

  • 18. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age.
    Lorenzo JI, López A, Altisent C, Aznar JA.
    Br J Haematol; 2001 Jun 07; 113(3):600-3. PubMed ID: 11380444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.